 |
|
MVA-PSA-PAP prostate cancer vaccine
A cancer vaccine consisting of a recombinant modified vaccinia Ankara (MVA) viral vector encoding genes for prostate specific antigen (PSA) and prostate acid phosphatase (PAP) with potential immunostimulatory and antineoplastic activities. Upon administration, MVA-PSA-PAP prostate cancer vaccine
expresses PSA and PAP peptides, which may elicit humoral and cellular immune responses against prostate cancer cells expressing PSA and PAP. Multi-antigen vaccine therapy may be more efficacious than single-antigen therapy vaccine therapy.
Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | modified vaccinia Ankara (Bavarian Nordic) prostate cancer vaccine
MVA-BN-PRO | | |
|
|
